128 related articles for article (PubMed ID: 17873709)
1. Increase in plasma concentration of amisulpride after addition of concomitant lithium.
Bergemann N; Abu-Tair F; Kress KR; Parzer P; Kopitz J
J Clin Psychopharmacol; 2007 Oct; 27(5):546-9. PubMed ID: 17873709
[No Abstract] [Full Text] [Related]
2. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
[TBL] [Abstract][Full Text] [Related]
3. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
Müller MJ; Eich FX; Regenbogen B; Sachse J; Härtter S; Hiemke C
J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411
[TBL] [Abstract][Full Text] [Related]
4. Pregabalin-associated increase of clozapine serum levels.
Englisch S; Alm B; Meyer-Lindenberg A; Zink M
J Clin Psychopharmacol; 2012 Feb; 32(1):127. PubMed ID: 22217943
[No Abstract] [Full Text] [Related]
5. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
Bergemann N; Kopitz J; Kress KR; Frick A
Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
[TBL] [Abstract][Full Text] [Related]
6. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyolysis following dose increase of clozapine and combination therapy with lithium.
Tseng KC; Hwang TJ
J Clin Psychopharmacol; 2009 Aug; 29(4):398-9. PubMed ID: 19593187
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
[No Abstract] [Full Text] [Related]
9. Neuroleptic malignant syndrome.
Yasugi S; Garg V; Been G; Magoulas P
Aust N Z J Psychiatry; 2010 Jun; 44(6):584. PubMed ID: 20482421
[No Abstract] [Full Text] [Related]
10. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
Cook B; Hoogenboom G
Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
[TBL] [Abstract][Full Text] [Related]
11. Bipolar disorder.
Belmaker RH
N Engl J Med; 2004 Jul; 351(5):476-86. PubMed ID: 15282355
[No Abstract] [Full Text] [Related]
12. [The features of atypical neuroleptic amisulpride action].
Grigor'eva EA; Ritskov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638
[No Abstract] [Full Text] [Related]
13. Estimation of rac-amisulpride transfer into milk and of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia.
Teoh S; Ilett KF; Hackett LP; Kohan R
Breastfeed Med; 2011 Apr; 6(2):85-8. PubMed ID: 20925494
[TBL] [Abstract][Full Text] [Related]
14. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
Zink M; Knopf U; Henn FA; Thome J
Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
[TBL] [Abstract][Full Text] [Related]
15. Reversible skin rash in a bipolar disorder patient on first use of lithium.
Wang EH; Yang AC
Psychiatry Clin Neurosci; 2013 Jul; 67(5):365. PubMed ID: 23859668
[No Abstract] [Full Text] [Related]
16. [Long-term use of 200 mg Dogmatil. Apropos of 13 cases].
Planche R
Sem Hop; 1984 Mar; 60(13):944-8. PubMed ID: 6144185
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
[TBL] [Abstract][Full Text] [Related]
18. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C
Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163
[TBL] [Abstract][Full Text] [Related]
19. Transient hyperproinsulinemia during treatment with clozapine and amisulpride.
Rettenbacher MA; Hummer M; Fleischhacker WW; Lechleitner M
J Clin Psychiatry; 2004 Jun; 65(6):878-9. PubMed ID: 15291669
[No Abstract] [Full Text] [Related]
20. Hyperprolactinaemia with amisulpride.
Ružić K; Grahovac T; Graovac M; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
Psychiatr Danub; 2011 Mar; 23(1):92-4. PubMed ID: 21448106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
